UMP Healthcare Holdings
Market Cap
HK$874.0m
Last Updated
2021/01/23 10:23 UTC
Data Sources
Company Financials
Executive Summary
UMP Healthcare Holdings Limited, an investment holding company, provides a range of medical and healthcare services in the People’s Republic of China. More Details
Rewards
Risk Analysis
Snowflake Analysis
Flawless balance sheet with solid track record.
Share Price & News
How has UMP Healthcare Holdings's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 722 is not significantly more volatile than the rest of Hong Kong stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: 722's weekly volatility (6%) has been stable over the past year.
Market Performance
7 Day Return
-0.9%
722
12.1%
HK Healthcare
3.5%
HK Market
1 Year Return
-18.0%
722
-7.6%
HK Healthcare
15.1%
HK Market
Return vs Industry: 722 underperformed the Hong Kong Healthcare industry which returned -9.4% over the past year.
Return vs Market: 722 underperformed the Hong Kong Market which returned 17.5% over the past year.
Shareholder returns
| 722 | Industry | Market | |
|---|---|---|---|
| 7 Day | -0.9% | 12.1% | 3.5% |
| 30 Day | -1.7% | 12.4% | 12.7% |
| 90 Day | -7.3% | 25.5% | 18.1% |
| 1 Year | -15.9%-18.0% | -5.1%-7.6% | 19.7%15.1% |
| 3 Year | -35.4%-39.4% | -41.6%-45.3% | -5.1%-15.1% |
| 5 Year | 18.2%7.5% | -24.0%-31.3% | 65.1%37.0% |
Long-Term Price Volatility Vs. Market
How volatile is UMP Healthcare Holdings's share price compared to the market and industry in the last 5 years?
Simply Wall St News
4 days ago | Simply Wall St
Will Weakness in UMP Healthcare Holdings Limited's (HKG:722) Stock Prove Temporary Given Strong Fundamentals?2 weeks ago | Simply Wall St
Are Insiders Buying UMP Healthcare Holdings Limited (HKG:722) Stock?1 month ago | Simply Wall St
Here's How We Evaluate UMP Healthcare Holdings Limited's (HKG:722) DividendValuation
Is UMP Healthcare Holdings undervalued compared to its fair value and its price relative to the market?
>50%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: 722 (HK$1.14) is trading below our estimate of fair value (HK$17.29)
Significantly Below Fair Value: 722 is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: 722 is good value based on its PE Ratio (14.6x) compared to the HK Healthcare industry average (21.5x).
PE vs Market: 722 is poor value based on its PE Ratio (14.6x) compared to the Hong Kong market (12x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 722's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 722's PB Ratio (1.4x) is in line with the HK Healthcare industry average.
Next Steps
Future Growth
How is UMP Healthcare Holdings forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
26.9%
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as UMP Healthcare Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Next Steps
- Examine whether UMP Healthcare Holdings is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
- UMP Healthcare Holdings competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Healthcare industry.
Past Performance
How has UMP Healthcare Holdings performed over the past 5 years?
16.9%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 722 has high quality earnings.
Growing Profit Margin: 722's current net profit margins (10.5%) are higher than last year (2.3%).
Past Earnings Growth Analysis
Earnings Trend: 722's earnings have grown by 16.9% per year over the past 5 years.
Accelerating Growth: 722's earnings growth over the past year (348.5%) exceeds its 5-year average (16.9% per year).
Earnings vs Industry: 722 earnings growth over the past year (348.5%) exceeded the Healthcare industry -9.1%.
Return on Equity
High ROE: 722's Return on Equity (9%) is considered low.
Next Steps
Financial Health
How is UMP Healthcare Holdings's financial position?
Financial Position Analysis
Short Term Liabilities: 722's short term assets (HK$388.9M) exceed its short term liabilities (HK$159.8M).
Long Term Liabilities: 722's short term assets (HK$388.9M) exceed its long term liabilities (HK$61.0M).
Debt to Equity History and Analysis
Debt Level: 722 is debt free.
Reducing Debt: 722 has not had any debt for past 5 years.
Debt Coverage: 722 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 722 has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Next Steps
Dividend
What is UMP Healthcare Holdings's current dividend yield, its reliability and sustainability?
2.89%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 722's dividend (2.89%) is higher than the bottom 25% of dividend payers in the Hong Kong market (2.06%).
High Dividend: 722's dividend (2.89%) is low compared to the top 25% of dividend payers in the Hong Kong market (6.48%).
Stability and Growth of Payments
Stable Dividend: 722 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 722's dividend payments have increased, but the company has only paid a dividend for 4 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (42.4%), 722's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
5.4yrs
Average management tenure
CEO
Yiu Kwong Sun (77 yo)
5.42yrs
Tenure
HK$8,140,000
Compensation
Dr. Yiu Kwong Sun has been Chief Executive Officer at UMP Healthcare Holdings Limited since August 29, 2015 and serves as its Chairman. Dr. Sun has been Executive Director of UMP Healthcare Holdings sine A...
CEO Compensation Analysis
Compensation vs Market: Yiu Kwong's total compensation ($USD1.05M) is above average for companies of similar size in the Hong Kong market ($USD230.42K).
Compensation vs Earnings: Yiu Kwong's compensation has been consistent with company performance over the past year.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 5.42yrs | HK$8.14m | 28.83% HK$ 251.9m | |
| MD & Executive Director | 6.17yrs | HK$4.43m | 2.34% HK$ 20.5m | |
| Executive Director | 5.42yrs | HK$330.00k | 0.013% HK$ 114.0k | |
| Executive Director | no data | HK$330.00k | 2.11% HK$ 18.4m | |
| Executive Director | no data | HK$2.75m | 0.18% HK$ 1.6m | |
| Executive Director | 2.92yrs | HK$330.00k | 2.61% HK$ 22.8m | |
| People & Corporate Affairs Director | 1yr | no data | no data | |
| VP & Chief Operation Officer of UMP Healthcare China | 1.67yrs | no data | no data | |
| Deputy General Manager & Company Secretary | 5.42yrs | no data | no data |
5.4yrs
Average Tenure
48yo
Average Age
Experienced Management: 722's management team is seasoned and experienced (5.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 5.42yrs | HK$8.14m | 28.83% HK$ 251.9m | |
| MD & Executive Director | 6.17yrs | HK$4.43m | 2.34% HK$ 20.5m | |
| Executive Director | 5.42yrs | HK$330.00k | 0.013% HK$ 114.0k | |
| Executive Director | no data | HK$330.00k | 2.11% HK$ 18.4m | |
| Executive Director | no data | HK$2.75m | 0.18% HK$ 1.6m | |
| Executive Director | 2.92yrs | HK$330.00k | 2.61% HK$ 22.8m | |
| Independent Non-Executive Director | 5.17yrs | HK$274.00k | 0.029% HK$ 250.8k | |
| Independent Non-Executive Director | 5.17yrs | HK$224.00k | 0.0026% HK$ 22.8k | |
| Independent Non-Executive Director | 5.17yrs | HK$224.00k | 0.043% HK$ 373.9k |
5.2yrs
Average Tenure
56yo
Average Age
Experienced Board: 722's board of directors are considered experienced (5.2 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
UMP Healthcare Holdings Limited's company bio, employee growth, exchange listings and data sources
Key Information
- Name: UMP Healthcare Holdings Limited
- Ticker: 722
- Exchange: SEHK
- Founded: 1990
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: HK$874.004m
- Shares outstanding: 766.67m
- Website: https://www2.ump.com.hk
Number of Employees
Location
- UMP Healthcare Holdings Limited
- Wing On House
- Room 1404–1408
- Central
- Hong Kong
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| 722 | SEHK (The Stock Exchange of Hong Kong Ltd.) | Yes | Ordinary shares | HK | HKD | Nov 2015 |
Biography
UMP Healthcare Holdings Limited, an investment holding company, provides a range of medical and healthcare services in the People’s Republic of China. It operates through two segments, Corporate Healthcare...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/01/23 10:23 |
| End of Day Share Price | 2021/01/22 00:00 |
| Earnings | 2020/06/30 |
| Annual Earnings | 2020/06/30 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.